Reduction in dipyridamole-induced single-photon emission computed tomography myocardial defect size by beta-blockers: time to re-examine the patient preparation protocol for pharmacologic stress testing.
Gerson
Myron C
MC
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D003327:Coronary Disease / Q000000981:diagnostic imaging* / Q000503:physiopathology*; D004176:Dipyridamole; D004311:Double-Blind Method; D005080:Exercise Test; D006801:Humans; D008790:Metoprolol / Q000008:administration & dosage / Q000494:pharmacology*; D011446:Prospective Studies; D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi; D015899:Tomography, Emission-Computed, Single-Photon; D014665:Vasodilator Agents
D000319:Adrenergic beta-Antagonists; D019275:Radiopharmaceuticals; D014665:Vasodilator Agents; D004176:Dipyridamole; D017256:Technetium Tc 99m Sestamibi; D008790:Metoprolol